Tapewire

Nasdaq · USD

LSTA

LISATA THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
7814
SEC CIK
0000320017
Parsed reports
165

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 09, 2017 Filed Jan 31, 2017 23:50 UTC GrantOptions to Purchase Common Stock · Derivative 2,750 $0.00 Strike: $3.54 $0.00
Disclosure

SEC source: 0001144204-17-005181 · v457999_4.xml · derivative · entry 2

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,750

Underlying: Common Stock · 2,750 shares

Expires 2027-01-09

Read SEC document
January 09, 2017 Filed Jan 31, 2017 23:50 UTC GrantCommon Stock 1,650 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-005181 · v457999_4.xml · nonDerivative · entry 1

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,177

F1 · shares: Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018.

F2 · balance_after: Includes 2,775 shares of unvested restricted stock granted under the Issuer's compensation plans.

Read SEC document
January 09, 2017 Filed Jan 31, 2017 23:49 UTC GrantOptions to Purchase Common Stock · Derivative 2,750 $0.00 Strike: $3.54 $0.00
Disclosure

SEC source: 0001144204-17-005180 · v457998_4.xml · derivative · entry 2

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,750

Underlying: Common Stock · 2,750 shares

Expires 2027-01-09

Read SEC document
January 09, 2017 Filed Jan 31, 2017 23:49 UTC GrantCommon Stock 1,650 $0.00 $0.00
Disclosure

SEC source: 0001144204-17-005180 · v457998_4.xml · nonDerivative · entry 1

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,150

F1 · shares: Represents 1,650 shares of restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018.

F2 · balance_after: Includes 4,150 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan.

Read SEC document
November 21, 2016 Filed Nov 25, 2016 11:16 UTC
Wei EricDirector
SaleCommon Stock 500 $4.20 $2,100.00
Disclosure

SEC source: 0001144204-16-136487 · v453890_4.xml · nonDerivative · entry 1

Wei Eric · CIK 0001368570 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,964,228

F1 · ownership.nature: Following the reported transactions, 1,952,228 shares of Common Stock of the Issuer are held by RimAsia Capital Partners L.P., a Cayman Islands exempted limited partnership ("RimAsia LP"), and 12,000 shares of Common Stock of the Issuer are held by RimAsia Capital Partners Manager, Ltd., a Cayman Islands exempted company ("RimAsia Manager").

F2 · ownership.nature: RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Manager is the Fund Manager of RimAsia GP and the Manager of RimAsia LP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP, a director of RimAsia Capital Partners GP, Ltd. and a director of RimAsia Manager. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP and RimAsia Manager. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose.

Read SEC document
October 25, 2016 Filed Nov 10, 2016 21:06 UTC
Talamo JosephSVP and CFO
Tax withholdingCommon Stock 176 $4.12 $725.12
Disclosure

SEC source: 0001144204-16-133280 · v452731_4.xml · nonDerivative · entry 1

Talamo Joseph · CIK 0001524547 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,423

F1 · balance_after: Includes 5,254 shares of unvested restricted stock.

Read SEC document
October 25, 2016 Filed Nov 10, 2016 21:06 UTC
Preti Robert ADirector · See Remarks
Tax withholdingCommon Stock 164 $4.12 $675.68
Disclosure

SEC source: 0001144204-16-133278 · v452730_4.xml · nonDerivative · entry 1

Preti Robert A · CIK 0001510186 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,331

F1 · balance_after: Includes 4,268 shares of unvested restricted stock.

Read SEC document
October 25, 2016 Filed Nov 10, 2016 21:06 UTC
Mazzo David JDirector · Chief Executive Officer
Tax withholdingCommon Stock 457 $4.12 $1,882.84
Disclosure

SEC source: 0001144204-16-133276 · v452729_4.xml · nonDerivative · entry 1

Mazzo David J · CIK 0001334549 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,238

F1 · balance_after: Includes 15,468 shares of unvested restricted stock.

Read SEC document
October 25, 2016 Filed Nov 10, 2016 21:05 UTC Tax withholdingCommon Stock 176 $4.12 $725.12
Disclosure

SEC source: 0001144204-16-133272 · v452728_4.xml · nonDerivative · entry 1

LOSORDO DOUGLAS W · CIK 0001583810 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,851

F1 · balance_after: Includes 4,271 shares of unvested restricted stock.

Read SEC document
October 10, 2016 Filed Oct 12, 2016 13:06 UTC GrantStock Option · Derivative 4,150 $0.00 Strike: $4.66 $0.00
Disclosure

SEC source: 0001144204-16-127776 · v450347_4.xml · derivative · entry 2

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,150

Underlying: Common Stock · 4,150 shares

Expires 2026-10-10

F1 · price: This grant was made in connection with the Reporting Person's appointment to the Issuer's board of directors, audit committee and nominating and corporate governance committee.

F3 · derivative.exercise_date: The stock options vest in equal annual installments over a three-year period, commencing on the first anniversary of the grant date.

Read SEC document
October 10, 2016 Filed Oct 12, 2016 13:06 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001144204-16-127776 · v450347_4.xml · nonDerivative · entry 1

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

F1 · price: This grant was made in connection with the Reporting Person's appointment to the Issuer's board of directors, audit committee and nominating and corporate governance committee.

F2 · balance_after: Represents 2,500 shares of restricted stock that will vest in equal annual installments over a three-year period, commencing on the first anniversary of the grant date.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 20:32 UTC
Talamo JosephSVP and CFO
GrantStock Option · Derivative 13,377 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0001144204-16-126315 · v449787_4.xml · derivative · entry 1

Talamo Joseph · CIK 0001524547 · SVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,377

Underlying: Common Stock · 13,377 shares

Expires 2026-09-29

F1 · security: These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 20:32 UTC
Preti Robert ADirector · See Remarks
GrantStock Option · Derivative 20,894 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0001144204-16-126314 · v449789_4.xml · derivative · entry 1

Preti Robert A · CIK 0001510186 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,894

Underlying: Common Stock · 20,894 shares

Expires 2026-09-29

F1 · security: These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 20:31 UTC
Mazzo David JDirector · Chief Executive Officer
GrantStock Option · Derivative 50,919 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0001144204-16-126313 · v449792_4.xml · derivative · entry 1

Mazzo David J · CIK 0001334549 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,919

Underlying: Common Stock · 50,919 shares

Expires 2026-09-29

F1 · security: These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 20:31 UTC GrantStock Option · Derivative 17,199 $0.00 Strike: $4.77 $0.00
Disclosure

SEC source: 0001144204-16-126311 · v449793_4.xml · derivative · entry 1

LOSORDO DOUGLAS W · CIK 0001583810 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,199

Underlying: Common Stock · 17,199 shares

Expires 2026-09-29

F1 · security: These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.